Cytokinetics
CYTK
#2364
Rank
A$11.41 B
Marketcap
A$93.35
Share price
-3.34%
Change (1 day)
18.30%
Change (1 year)

Cytokinetics (CYTK) - Total debt

Total debt on the balance sheet as of September 2025 : A$1.80 Billion

According to Cytokinetics 's latest financial reports the company's total debt is A$1.80 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Cytokinetics - Total debt on balance sheet (from 2003 to 2025)

Total debt by year

Year Total debt Change
2024-12-31A$1.26 B14.3%
2023-12-31A$1.10 B0.61%
2022-12-31A$1.10 B196.13%
2021-12-31A$0.37 B106.06%
2020-12-31A$0.18 B-7.03%
2019-12-31A$0.19 B217.04%
2018-12-31A$61.29 M50.6%
2017-12-31A$40.7 M-1.81%
2016-12-31A$41.45 M106.29%
2015-12-31A$20.09 M
2012-12-31N/A-100%
2011-12-31A$0.14 M-84.71%
2010-12-31A$0.96 M-93.2%
2009-12-31A$14.25 M116.69%
2008-12-31A$6.57 M-33.83%
2007-12-31A$9.93 M-27.69%
2006-12-31A$13.74 M7.42%
2005-12-31A$12.79 M-5.64%
2004-12-31A$13.55 M-0.04%
2003-12-31A$13.56 M-19.48%
2002-12-31A$16.84 M143.92%
2001-12-31A$6.9 M257.91%
2000-12-31A$1.92 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Ligand Pharmaceuticals
LGND
A$0.67 B-62.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
A$56.56 M-96.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A$0.29 B-83.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$82.20 B 4,460.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
A$1.02 B-43.10%๐Ÿ‡บ๐Ÿ‡ธ USA